Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context

Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gwendolien Vanderschaeghe, Jolien Schaeverbeke, Rose Bruffaerts, Rik Vandenberghe, Kris Dierickx
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2017-12-01
Series:Alzheimer’s Research & Therapy
Assuntos:
Ethics
Amnestic MCI
MCI due to AD
Research
Qualitative research
Disclosure
Acceso en liña:http://link.springer.com/article/10.1186/s13195-017-0321-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares